NANCYWEIGELNANCY WEIGEL0.000000000000000.000000000000002552WEIGEL, NANCYProfessor Emeritusprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25333515Grimm SL, Ward RD, Obr AE, Franco HL, Fernandez-Valdivia R, Kim JS, Roberts JM, Jeong JW, DeMayo FJ, Lydon JP, Edwards DP, Weigel NLMolecular endocrinology (Baltimore, Md.)A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo. Mol Endocrinol. 2014 Dec; 28(12):2025-37.Mol Endocrinol2014-12-01T00:00:002014A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo.25489091He B, Lanz RB, Fiskus W, Geng C, Yi P, Hartig SM, Rajapakshe K, Shou J, Wei L, Shah SS, Foley C, Chew SA, Eedunuri VK, Bedoya DJ, Feng Q, Minami T, Mitsiades CS, Frolov A, Weigel NL, Hilsenbeck SG, Rosen DG, Palzkill T, Ittmann MM, Song Y, Coarfa C, O'Malley BW, Mitsiades NProceedings of the National Academy of Sciences of the United States of AmericaGATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci U S A. 2014 Dec 23; 111(51):18261-6.Proc Natl Acad Sci U S A2014-12-08T00:00:002014GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.Authorship 8021511Authorship 806785Authorship 820033Authorship 832393Authorship 853378Authorship 858642Authorship 874641Authorship 903741Authorship 889642Authorship 932996Authorship 961882Authorship 977275Authorship 1014444Authorship 1018042Authorship 1024147Authorship 1036304Authorship 1065964Authorship 10725412Authorship 117735Authorship 1202713Authorship 1214605Authorship 141226Authorship 214693Authorship 215141Authorship 162982125869229Weigel NLHormones & cancerHormones and Cancer: an exciting young journal for an expanding field of basic, translational, and clinical study. Horm Cancer. 2015 Jun; 6(2-3):65-6.Horm Cancer2015-04-14T00:00:002015Hormones and Cancer: an exciting young journal for an expanding field of basic, translational, and clinical study.Authorship 305063Authorship 316392Authorship 330674Authorship 342743Authorship 366132Authorship 367464Authorship 376572Authorship 381402Genitourinary Medical OncologyMD AndersonTIMOTHYTHOMPSONTIMOTHY THOMPSON9463THOMPSON, TIMOTHYProfessorCHRISTOPHER JLOGOTHETISCHRISTOPHER J LOGOTHETIS8480LOGOTHETIS, CHRISTOPHER JProfessorAuthorship 477584Authorship 536223Authorship 569013Authorship 603502Authorship 605741Authorship 67669Authorship 729572Authorship 764461Authorship 831375Authorship 86229Authorship 9393511Authorship 953523024703Kulomaa MS, Weigel NL, Kleinsek DA, Beattie WG, Conneely OM, March C, Zarucki-Schulz T, Schrader WT, O'Malley BWBiochemistryAmino acid sequence of a chicken heat shock protein derived from the complementary DNA nucleotide sequence. Biochemistry. 1986 Oct 07; 25(20):6244-51.Biochemistry1986-10-07T00:00:001986Amino acid sequence of a chicken heat shock protein derived from the complementary DNA nucleotide sequence.3167984Tsai SY, Carlstedt-Duke J, Weigel NL, Dahlman K, Gustafsson JA, Tsai MJ, O'Malley BWCellMolecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell. 1988 Oct 21; 55(2):361-9.Cell1988-10-21T00:00:001988Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation.3578794Denner LA, Weigel NL, Schrader WT, O'Malley BWAnalytical biochemistryHigh-yield high-performance liquid chromatographic analysis of steroid hormone receptors on glass columns. Anal Biochem. 1987 Mar; 161(2):291-9.Anal Biochem1987-03-01T00:00:001987High-yield high-performance liquid chromatographic analysis of steroid hormone receptors on glass columns.3695483Denner LA, Bingman WE, Greene GL, Weigel NLJournal of steroid biochemistryPhosphorylation of the chicken progesterone receptor. J Steroid Biochem. 1987; 27(1-3):235-43.J Steroid Biochem1987-01-01T00:00:001987Phosphorylation of the chicken progesterone receptor.7025136Schrader WT, Birnbaumer ME, Hughes MR, Weigel NL, Grody WW, O'Malley BWRecent progress in hormone researchStudies on the structure and function of the chicken progesterone receptor. Recent Prog Horm Res. 1981; 37:583-633.Recent Prog Horm Res1981-01-01T00:00:001981Studies on the structure and function of the chicken progesterone receptor.7483325Bai W, Weigel NLVitamins and hormonesPhosphorylation and steroid hormone action. Vitam Horm. 1995; 51:289-313.Vitam Horm1995-01-01T00:00:001995Phosphorylation and steroid hormone action.4942330Anderson B, Weigel N, Kundig W, Roseman SThe Journal of biological chemistrySugar transport. 3. Purification and properties of a phosphocarrier protein (HPr) of the phosphoenolpyruvate-dependent phosphotransferase system of Escherichia coli. J Biol Chem. 1971 Nov 25; 246(22):7023-33.J Biol Chem1971-11-25T00:00:001971Sugar transport. 3. Purification and properties of a phosphocarrier protein (HPr) of the phosphoenolpyruvate-dependent phosphotransferase system of Escherichia coli.6207857Edwards DP, Weigel NL, Schrader WT, O'Malley BW, McGuire WLBiochemistryStructural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein. Biochemistry. 1984 Sep 11; 23(19):4427-35.Biochemistry1984-09-11T00:00:001984Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein.6272798Weigel NL, Tash JS, Means AR, Schrader WT, O'Malley BWBiochemical and biophysical research communicationsPhosphorylation of hen progesterone receptor by cAMP dependent protein kinase. Biochem Biophys Res Commun. 1981 Sep 16; 102(1):513-9.Biochem Biophys Res Commun1981-09-16T00:00:001981Phosphorylation of hen progesterone receptor by cAMP dependent protein kinase.7317354Weigel NL, Pousette A, Schrader WT, O'Malley BWBiochemistryAnalysis of chicken progesterone receptor structure using a spontaneous sheep antibody. Biochemistry. 1981 Nov 24; 20(24):6798-803.Biochemistry1981-11-24T00:00:001981Analysis of chicken progesterone receptor structure using a spontaneous sheep antibody.6593705Zarucki-Schulz T, Kulomaa MS, Headon DR, Weigel NL, Baez M, Edwards DP, McGuire WL, Schrader WT, O'Malley BWProceedings of the National Academy of Sciences of the United States of AmericaMolecular cloning of a cDNA for the chicken progesterone receptor B antigen. Proc Natl Acad Sci U S A. 1984 Oct; 81(20):6358-62.Proc Natl Acad Sci U S A1984-10-01T00:00:001984Molecular cloning of a cDNA for the chicken progesterone receptor B antigen.8058067Zhang Y, Bai W, Allgood VE, Weigel NLMolecular endocrinology (Baltimore, Md.)Multiple signaling pathways activate the chicken progesterone receptor. Mol Endocrinol. 1994 May; 8(5):577-84.Mol Endocrinol1994-05-01T00:00:001994Multiple signaling pathways activate the chicken progesterone receptor.8155647Hilliard GM, Cook RG, Weigel NL, Pike JWBiochemistry1,25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry. 1994 Apr 12; 33(14):4300-11.Biochemistry1994-04-12T00:00:0019941,25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation.8389450Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DPProceedings of the National Academy of Sciences of the United States of AmericaThe progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci U S A. 1993 May 15; 90(10):4441-5.Proc Natl Acad Sci U S A1993-05-15T00:00:001993The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.8469237Poletti A, Weigel NLMolecular endocrinology (Baltimore, Md.)Identification of a hormone-dependent phosphorylation site adjacent to the DNA-binding domain of the chicken progesterone receptor. Mol Endocrinol. 1993 Feb; 7(2):241-6.Mol Endocrinol1993-02-01T00:00:001993Identification of a hormone-dependent phosphorylation site adjacent to the DNA-binding domain of the chicken progesterone receptor.8557652Beck CA, Zhang Y, Weigel NL, Edwards DPThe Journal of biological chemistryTwo types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor. J Biol Chem. 1996 Jan 12; 271(2):1209-17.J Biol Chem1996-01-12T00:00:001996Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor.7626494Edwards DP, Altmann M, DeMarzo A, Zhang Y, Weigel NL, Beck CAThe Journal of steroid biochemistry and molecular biologyProgesterone receptor and the mechanism of action of progesterone antagonists. J Steroid Biochem Mol Biol. 1995 Jun; 53(1-6):449-58.J Steroid Biochem Mol Biol1995-06-01T00:00:001995Progesterone receptor and the mechanism of action of progesterone antagonists.7626502Weigel NL, Bai W, Zhang Y, Beck CA, Edwards DP, Poletti AThe Journal of steroid biochemistry and molecular biologyPhosphorylation and progesterone receptor function. J Steroid Biochem Mol Biol. 1995 Jun; 53(1-6):509-14.J Steroid Biochem Mol Biol1995-06-01T00:00:001995Phosphorylation and progesterone receptor function.8702703Nazareth LV, Weigel NLThe Journal of biological chemistryActivation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem. 1996 Aug 16; 271(33):19900-7.J Biol Chem1996-08-16T00:00:001996Activation of the human androgen receptor through a protein kinase A signaling pathway.8702648Beck CA, Zhang Y, Altmann M, Weigel NL, Edwards DPThe Journal of biological chemistryStoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system. J Biol Chem. 1996 Aug 09; 271(32):19546-55.J Biol Chem1996-08-09T00:00:001996Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system.8920964Weigel NLThe Biochemical journalSteroid hormone receptors and their regulation by phosphorylation. Biochem J. 1996 Nov 01; 319 ( Pt 3):657-67.Biochem J1996-11-01T00:00:001996Steroid hormone receptors and their regulation by phosphorylation.9075707Blutt SE, Allegretto EA, Pike JW, Weigel NLEndocrinology1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology. 1997 Apr; 138(4):1491-7.Endocrinology1997-04-01T00:00:0019971,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.9038175Giffin W, Kwast-Welfeld J, Rodda DJ, Pr?fontaine GG, Traykova-Andonova M, Zhang Y, Weigel NL, Lefebvre YA, Hach? RJThe Journal of biological chemistrySequence-specific DNA binding and transcription factor phosphorylation by Ku Autoantigen/DNA-dependent protein kinase. Phosphorylation of Ser-527 of the rat glucocorticoid receptor. J Biol Chem. 1997 Feb 28; 272(9):5647-58.J Biol Chem1997-02-28T00:00:001997Sequence-specific DNA binding and transcription factor phosphorylation by Ku Autoantigen/DNA-dependent protein kinase. Phosphorylation of Ser-527 of the rat glucocorticoid receptor.1316549Beck CA, Weigel NL, Edwards DPMolecular endocrinology (Baltimore, Md.)Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol. 1992 Apr; 6(4):607-20.Mol Endocrinol1992-04-01T00:00:001992Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.7983041Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NLThe Journal of biological chemistryIdentification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J Biol Chem. 1994 Dec 09; 269(49):31034-40.J Biol Chem1994-12-09T00:00:001994Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II.9171245Zhang Y, Beck CA, Poletti A, Clement JP, Prendergast P, Yip TT, Hutchens TW, Edwards DP, Weigel NLMolecular endocrinology (Baltimore, Md.)Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol. 1997 Jun; 11(6):823-32.Mol Endocrinol1997-06-01T00:00:001997Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo.9488452Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DPMolecular and cellular biologyThe nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol. 1998 Mar; 18(3):1369-78.Mol Cell Biol1998-03-01T00:00:001998The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.8260729Edwards DP, Weigel NL, Nordeen SK, Beck CABreast cancer research and treatmentModulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat. 1993; 27(1-2):41-56.Breast Cancer Res Treat1993-01-01T00:00:001993Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.9459185Mangal RK, Wiehle RD, Poindexter AN, Weigel NLThe Journal of steroid biochemistry and molecular biologyDifferential expression of uterine progesterone receptor forms A and B during the menstrual cycle. J Steroid Biochem Mol Biol. 1997 Nov-Dec; 63(4-6):195-202.J Steroid Biochem Mol Biol1997-11-01T00:00:001997Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle.10352118Blutt SE, Weigel NLProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)Vitamin D and prostate cancer. Proc Soc Exp Biol Med. 1999 Jun; 221(2):89-98.Proc Soc Exp Biol Med1999-06-01T00:00:001999Vitamin D and prostate cancer.10421772Walker C, Ahmed SA, Brown T, Ho SM, Hodges L, Lucier G, Russo J, Weigel N, Weise T, Vandenbergh JEnvironmental health perspectivesSpecies, interindividual, and tissue specificity in endocrine signaling. Environ Health Perspect. 1999 Aug; 107 Suppl 4:619-24.Environ Health Perspect1999-08-01T00:00:001999Species, interindividual, and tissue specificity in endocrine signaling.Authorship 2996041Authorship 3000431126305704Weigel NLHormones & cancerHormones and Cancer--Looking Forward. Horm Cancer. 2015 Dec; 6(5-6):189-90.Horm Cancer2015-08-25T00:00:002015Hormones and Cancer--Looking Forward.26378018Shafi AA, Putluri V, Arnold JM, Tsouko E, Maity S, Roberts JM, Coarfa C, Frigo DE, Putluri N, Sreekumar A, Weigel NLOncotargetDifferential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells. Oncotarget. 2015 Oct 13; 6(31):31997-2012.Oncotarget2015-10-13T00:00:002015Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.11110801Knotts TA, Orkiszewski RS, Cook RG, Edwards DP, Weigel NLThe Journal of biological chemistryIdentification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem. 2001 Mar 16; 276(11):8475-83.J Biol Chem2000-12-07T00:00:002000Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.10196362Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MAHuman molecular geneticsPolyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet. 1999 May; 8(5):731-41.Hum Mol Genet1999-05-01T00:00:001999Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.11780928Polek TC, Weigel NLJournal of andrologyVitamin D and prostate cancer. J Androl. 2002 Jan-Feb; 23(1):9-17.J Androl2002-01-01T00:00:002002Vitamin D and prostate cancer.10660621Rowan BG, Weigel NL, O'Malley BWThe Journal of biological chemistryPhosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem. 2000 Feb 11; 275(6):4475-83.J Biol Chem2000-02-11T00:00:002000Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway.One Baylor PlazaHouston, 77030TX1448113Weigel NL, Beck CA, Estes PA, Prendergast P, Altmann M, Christensen K, Edwards DPMolecular endocrinology (Baltimore, Md.)Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol Endocrinol. 1992 Oct; 6(10):1585-97.Mol Endocrinol1992-10-01T00:00:001992Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody.12231410Narayanan R, Smith CL, Weigel NLBoneVector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089. Bone. 2002 Sep; 31(3):381-8.Bone2002-09-01T00:00:002002Vector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089.1326555Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ, O'Malley BWThe Journal of biological chemistryHormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem. 1992 Sep 25; 267(27):19513-20.J Biol Chem1992-09-25T00:00:001992Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.10230405Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HAMolecular cellPhosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell. 1999 Apr; 3(4):521-6.Mol Cell1999-04-01T00:00:001999Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress.15042604Murthy S, Weigel NLThe Prostate1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway. Prostate. 2004 May 15; 59(3):282-91.Prostate2004-05-15T00:00:0020041alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway.10614618Blutt SE, McDonnell TJ, Polek TC, Weigel NLEndocrinologyCalcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology. 2000 Jan; 141(1):10-7.Endocrinology2000-01-01T00:00:002000Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.1738374Weigel NL, Carter TH, Schrader WT, O'Malley BWMolecular endocrinology (Baltimore, Md.)Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays. Mol Endocrinol. 1992 Jan; 6(1):8-14.Mol Endocrinol1992-01-01T00:00:001992Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays.10706079Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NLCancer researchA calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res. 2000 Feb 15; 60(4):779-82.Cancer Res2000-02-15T00:00:002000A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.10706109Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L, Zhao Y, DiConcini D, Puxeddu E, Esen A, Eastham J, Weigel NL, Lamb DJCancer researchAndrogen receptor mutations in prostate cancer. Cancer Res. 2000 Feb 15; 60(4):944-9.Cancer Res2000-02-15T00:00:002000Androgen receptor mutations in prostate cancer.15601848Narayanan R, Adigun AA, Edwards DP, Weigel NLMolecular and cellular biologyCyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol Cell Biol. 2005 Jan; 25(1):264-77.Mol Cell Biol2005-01-01T00:00:002005Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.74Professor10Assistant Professor48Distinguished Service Professor Emeritus14Associate Professor46Distinguished Emeritus Professor3Adjunct Associate Professor78Professor Emeritus6Adjunct Professor47Distinguished Service Professor27194471Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, Stossi F, Li H, Samanta S, Cao X, Tsouko E, Huang S, Frigo DE, Chan L, Edwards DP, Kaipparettu BA, Mitsiades N, Weigel NL, Mancini M, McGuire SE, Mehra R, Ittmann MM, Chinnaiyan AM, Putluri N, Palapattu GS, Michailidis G, Sreekumar ANature communicationsInhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016 05 19; 7:11612.Nat Commun2016-05-19T00:00:002016Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.12554787Galet C, Min L, Narayanan R, Kishi M, Weigel NL, Ascoli MMolecular endocrinology (Baltimore, Md.)Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathway. Mol Endocrinol. 2003 Mar; 17(3):411-22.Mol Endocrinol2002-11-27T00:00:002002Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathway.12566449Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CLThe Journal of biological chemistryMechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s). J Biol Chem. 2003 Apr 11; 278(15):12834-45.J Biol Chem2003-01-31T00:00:002003Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s).12634308Lamb DJ, Puxeddu E, Malik N, Stenoien DL, Nigam R, Saleh GY, Mancini M, Weigel NL, Marcelli MJournal of andrologyMolecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation. J Androl. 2003 Mar-Apr; 24(2):215-25.J Androl2003-03-01T00:00:002003Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation.12771131Agoulnik IU, Krause WC, Bingman WE, Rahman HT, Amrikachi M, Ayala GE, Weigel NLThe Journal of biological chemistryRepressors of androgen and progesterone receptor action. J Biol Chem. 2003 Aug 15; 278(33):31136-48.J Biol Chem2003-05-27T00:00:002003Repressors of androgen and progesterone receptor action.12809504Iyer D, Belaguli N, Fl?ck M, Rowan BG, Wei L, Weigel NL, Booth FW, Epstein HF, Schwartz RJ, Balasubramanyam ABiochemistryNovel phosphorylation target in the serum response factor MADS box regulates alpha-actin transcription. Biochemistry. 2003 Jun 24; 42(24):7477-86.Biochemistry2003-06-24T00:00:002003Novel phosphorylation target in the serum response factor MADS box regulates alpha-actin transcription.12858358Murthy S, Marcelli M, Weigel NLThe ProstateStable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3. Prostate. 2003 Sep 01; 56(4):293-304.Prostate2003-09-01T00:00:002003Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.16440331Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH, Mancini MAJournal of cellular biochemistryQuantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem. 2006 Jul 01; 98(4):770-88.J Cell Biochem2006-07-01T00:00:002006Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.Authorship 3213515Authorship 3234662726652902Trevi?o LS, Bolt MJ, Grimm SL, Edwards DP, Mancini MA, Weigel NLMolecular endocrinology (Baltimore, Md.)Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Mol Endocrinol. 2016 Feb; 30(2):158-72.Mol Endocrinol2015-12-11T00:00:002015Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.Authorship 3258281226968201Lopez SM, Agoulnik AI, Zhang M, Peterson LE, Suarez E, Gandarillas GA, Frolov A, Li R, Rajapakshe K, Coarfa C, Ittmann MM, Weigel NL, Agoulnik IUClinical cancer research : an official journal of the American Association for Cancer ResearchNuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression. Clin Cancer Res. 2016 08 01; 22(15):3937-49.Clin Cancer Res2016-03-11T00:00:002016Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.12488329Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA, Weigel NLEndocrinologyp53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Endocrinology. 2003 Jan; 144(1):50-60.Endocrinology2003-01-01T00:00:002003p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.12629413Bruckheimer EM, Spurgers K, Weigel NL, Logothetis C, McDonnell TJThe Journal of urologyRegulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells. J Urol. 2003 Apr; 169(4):1553-7.J Urol2003-04-01T00:00:002003Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.17904173Shen X, Mula RV, Li J, Weigel NL, Falzon MSteroidsPTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3). Steroids. 2007 Dec; 72(14):930-8.Steroids2007-08-15T00:00:002007PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3).15207749Narayanan R, Allen MR, Gaddy D, Bloomfield SA, Smith CL, Weigel NLBoneDifferential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089). Bone. 2004 Jul; 35(1):134-43.Bone2004-07-01T00:00:002004Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089).2082181Rodriguez R, Weigel NL, O'Malley BW, Schrader WTMolecular endocrinology (Baltimore, Md.)Dimerization of the chicken progesterone receptor in vitro can occur in the absence of hormone and DNA. Mol Endocrinol. 1990 Dec; 4(12):1782-90.Mol Endocrinol1990-12-01T00:00:001990Dimerization of the chicken progesterone receptor in vitro can occur in the absence of hormone and DNA.18497048Agoulnik IU, Weigel NLAdvances in experimental medicine and biologyAndrogen receptor coactivators and prostate cancer. Adv Exp Med Biol. 2008; 617:245-55.Adv Exp Med Biol2008-01-01T00:00:002008Androgen receptor coactivators and prostate cancer.BRYANNIKOLAIBRYAN NIKOLAI0.000000000000000.000000000000004904NIKOLAI, BRYANAssistant Professor15651061Stewart LV, Weigel NLThe ProstateRole of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Prostate. 2005 Jun 15; 64(1):9-19.Prostate2005-06-15T00:00:002005Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.15754350Murthy S, Agoulnik IU, Weigel NLThe ProstateAndrogen receptor signaling and vitamin D receptor action in prostate cancer cells. Prostate. 2005 Sep 01; 64(4):362-72.Prostate2005-09-01T00:00:002005Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.15798179Narayanan R, Edwards DP, Weigel NLMolecular and cellular biologyHuman progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol Cell Biol. 2005 Apr; 25(8):2885-98.Mol Cell Biol2005-04-01T00:00:002005Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.19463689Agoulnik IU, Weigel NLSteroidsCoactivator selective regulation of androgen receptor activity. Steroids. 2009 Aug; 74(8):669-74.Steroids2009-03-09T00:00:002009Coactivator selective regulation of androgen receptor activity.19904813Ward RD, Weigel NLBioFactors (Oxford, England)Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation. Biofactors. 2009 Nov-Dec; 35(6):528-36.Biofactors2009-11-01T00:00:002009Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.20147525Washington MN, Weigel NLEndocrinology1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion. Endocrinology. 2010 Apr; 151(4):1409-17.Endocrinology2010-02-10T00:00:0020101{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.1745818O'Malley BW, Tsai SY, Bagchi M, Weigel NL, Schrader WT, Tsai MJRecent progress in hormone researchMolecular mechanism of action of a steroid hormone receptor. Recent Prog Horm Res. 1991; 47:1-24; discussion 24-6.Recent Prog Horm Res1991-01-01T00:00:001991Molecular mechanism of action of a steroid hormone receptor.16140968Agoulnik IU, Vaid A, Bingman WE, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NLCancer researchRole of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res. 2005 Sep 01; 65(17):7959-67.Cancer Res2005-09-01T00:00:002005Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.15331595Narayanan R, Sepulveda VA, Falzon M, Weigel NLThe Journal of biological chemistryThe functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem. 2004 Nov 05; 279(45):47298-310.J Biol Chem2004-08-25T00:00:002004The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.21224358Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL, Agoulnik IUCancer researchDecreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res. 2011 Jan 15; 71(2):572-82.Cancer Res2011-01-11T00:00:002011Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.16352595Proia DA, Nannenga BW, Donehower LA, Weigel NLThe Journal of biological chemistryDual roles for the phosphatase PPM1D in regulating progesterone receptor function. J Biol Chem. 2006 Mar 17; 281(11):7089-101.J Biol Chem2005-12-13T00:00:002005Dual roles for the phosphatase PPM1D in regulating progesterone receptor function.15579801Agoulnik IU, Tong XW, Fischer DC, K?rner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DGThe Journal of clinical endocrinology and metabolismA germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab. 2004 Dec; 89(12):6340-7.J Clin Endocrinol Metab2004-12-01T00:00:002004A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.16417524Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JMThe Biochemical journalAkt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. Biochem J. 2006 May 01; 395(3):653-62.Biochem J2006-05-01T00:00:002006Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.15657432Srinivas H, Juroske DM, Kalyankrishna S, Cody DD, Price RE, Xu XC, Narayanan R, Weigel NL, Kurie JMMolecular and cellular biologyc-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol Cell Biol. 2005 Feb; 25(3):1054-69.Mol Cell Biol2005-02-01T00:00:002005c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.21550420Moore NL, Weigel NLThe international journal of biochemistry & cell biologyRegulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus. Int J Biochem Cell Biol. 2011 Aug; 43(8):1157-67.Int J Biochem Cell Biol2011-04-21T00:00:002011Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.16243370Sepulveda VA, Weigel NL, Falzon MSteroidsProstate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Steroids. 2006 Feb; 71(2):102-15.Steroids2005-10-21T00:00:002005Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.23152004He S, Zhang C, Shafi AA, Sequeira M, Acquaviva J, Friedland JC, Sang J, Smith DL, Weigel NL, Wada Y, Proia DAInternational journal of oncologyPotent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression. Int J Oncol. 2013 Jan; 42(1):35-43.Int J Oncol2012-11-14T00:00:002012Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.1911419McDonnell DP, Nawaz Z, Densmore C, Weigel NL, Pham TA, Clark JH, O'Malley BWThe Journal of steroid biochemistry and molecular biologyHigh level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J Steroid Biochem Mol Biol. 1991 Sep; 39(3):291-7.J Steroid Biochem Mol Biol1991-09-01T00:00:001991High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae.23380370Trevi?o LS, Bingman WE, Edwards DP, Nl WSteroidsThe requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific. Steroids. 2013 Jun; 78(6):542-7.Steroids2013-02-01T00:00:002013The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.2005127Allan GF, Ing NH, Tsai SY, Srinivasan G, Weigel NL, Thompson EB, Tsai MJ, O'Malley BWThe Journal of biological chemistrySynergism between steroid response and promoter elements during cell-free transcription. J Biol Chem. 1991 Mar 25; 266(9):5905-10.J Biol Chem1991-03-25T00:00:001991Synergism between steroid response and promoter elements during cell-free transcription.17132855Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JAPharmacological reviewsInternational Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev. 2006 Dec; 58(4):782-97.Pharmacol Rev2006-12-01T00:00:002006International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors.17207508Moore NL, Narayanan R, Weigel NLSteroidsCyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids. 2007 Feb; 72(2):202-9.Steroids2007-01-04T00:00:002007Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.17207919Weigel NL, Moore NLMolecular and cellular endocrinologyCyclins, cyclin dependent kinases, and regulation of steroid receptor action. Mol Cell Endocrinol. 2007 Feb; 265-266:157-61.Mol Cell Endocrinol2007-01-05T00:00:002007Cyclins, cyclin dependent kinases, and regulation of steroid receptor action.17525795Weigel NL, Moore NLNuclear receptor signalingKinases and protein phosphorylation as regulators of steroid hormone action. Nucl Recept Signal. 2007 May 17; 5:e005.Nucl Recept Signal2007-05-17T00:00:002007Kinases and protein phosphorylation as regulators of steroid hormone action.17556536Rudd MD, Gonzalez-Robayna I, Hernandez-Gonzalez I, Weigel NL, Bingman WE, Richards JSJournal of molecular endocrinologyConstitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity. J Mol Endocrinol. 2007 Jun; 38(6):673-90.J Mol Endocrinol2007-06-01T00:00:002007Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity.17867385Weigel NLNutrition reviewsInteractions between vitamin D and androgen receptor signaling in prostate cancer cells. Nutr Rev. 2007 Aug; 65(8 Pt 2):S116-7.Nutr Rev2007-08-01T00:00:002007Interactions between vitamin D and androgen receptor signaling in prostate cancer cells.18787043Agoulnik IU, Bingman WE, Nakka M, Li W, Wang Q, Liu XS, Brown M, Weigel NLMolecular endocrinology (Baltimore, Md.)Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase. Mol Endocrinol. 2008 Nov; 22(11):2420-32.Mol Endocrinol2008-09-11T00:00:002008Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.2153462Klein-Hitpass L, Tsai SY, Weigel NL, Allan GF, Riley D, Rodriguez R, Schrader WT, Tsai MJ, O'Malley BWCellThe progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell. 1990 Jan 26; 60(2):247-57.Cell1990-01-26T00:00:001990The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex.19164469Rohan JN, Weigel NLEndocrinology1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology. 2009 May; 150(5):2046-54.Endocrinology2009-01-22T00:00:0020091Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.2176746Denner LA, Weigel NL, Maxwell BL, Schrader WT, O'Malley BWScience (New York, N.Y.)Regulation of progesterone receptor-mediated transcription by phosphorylation. Science. 1990 Dec 21; 250(4988):1740-3.Science1990-12-21T00:00:001990Regulation of progesterone receptor-mediated transcription by phosphorylation.19533338De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, Chamness GC, Hilsenbeck SG, And? S, Fuqua SABreast cancer research and treatmentAndrogen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010 May; 121(1):1-11.Breast Cancer Res Treat2009-06-17T00:00:002009Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.19584236Bhatia V, Saini MK, Shen X, Bi LX, Qiu S, Weigel NL, Falzon MMolecular cancer therapeuticsEB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells. Mol Cancer Ther. 2009 Jul; 8(7):1787-98.Mol Cancer Ther2009-07-07T00:00:002009EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.Authorship 100464420008003Wardell SE, Narayanan R, Weigel NL, Edwards DPMolecular endocrinology (Baltimore, Md.)Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400. Mol Endocrinol. 2010 Feb; 24(2):335-45.Mol Endocrinol2009-12-11T00:00:002009Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.2398063Denner LA, Schrader WT, O'Malley BW, Weigel NLThe Journal of biological chemistryHormonal regulation and identification of chicken progesterone receptor phosphorylation sites. J Biol Chem. 1990 Sep 25; 265(27):16548-55.J Biol Chem1990-09-25T00:00:001990Hormonal regulation and identification of chicken progesterone receptor phosphorylation sites.2332444Schweers LA, Frank DE, Weigel NL, Sanders MMThe Journal of biological chemistryThe steroid-dependent regulatory element in the ovalbumin gene does not function as a typical steroid response element. J Biol Chem. 1990 May 05; 265(13):7590-5.J Biol Chem1990-05-05T00:00:001990The steroid-dependent regulatory element in the ovalbumin gene does not function as a typical steroid response element.23270728Nakka M, Agoulnik IU, Weigel NLThe international journal of biochemistry & cell biologyTargeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells. Int J Biochem Cell Biol. 2013 Apr; 45(4):763-72.Int J Biochem Cell Biol2012-12-25T00:00:002012Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.2583054Denner LA, Weigel NL, Schrader WT, O'Malley BWEndocrinologyHormone-dependent regulation of chicken progesterone receptor deoxyribonucleic acid binding and phosphorylation. Endocrinology. 1989 Dec; 125(6):3051-8.Endocrinology1989-12-01T00:00:001989Hormone-dependent regulation of chicken progesterone receptor deoxyribonucleic acid binding and phosphorylation.23380368Shafi AA, Cox MB, Weigel NLSteroidsAndrogen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression. Steroids. 2013 Jun; 78(6):548-54.Steroids2013-02-01T00:00:002013Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression.2689442Mak P, McDonnell DP, Weigel NL, Schrader WT, O'Malley BWThe Journal of biological chemistryExpression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae). J Biol Chem. 1989 Dec 25; 264(36):21613-8.J Biol Chem1989-12-25T00:00:001989Expression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae).2791998Weigel NL, Schrader WT, O'Malley BWEndocrinologyAntibodies to chicken progesterone receptor peptide 523-536 recognize a site exposed in receptor-deoxyribonucleic acid complexes but not in receptor-heat shock protein-90 complexes. Endocrinology. 1989 Nov; 125(5):2494-501.Endocrinology1989-11-01T00:00:001989Antibodies to chicken progesterone receptor peptide 523-536 recognize a site exposed in receptor-deoxyribonucleic acid complexes but not in receptor-heat shock protein-90 complexes.2710137Rodriguez R, Carson MA, Weigel NL, O'Malley BW, Schrader WTMolecular endocrinology (Baltimore, Md.)Hormone-induced changes in the in vitro DNA-binding activity of the chicken progesterone receptor. Mol Endocrinol. 1989 Feb; 3(2):356-62.Mol Endocrinol1989-02-01T00:00:001989Hormone-induced changes in the in vitro DNA-binding activity of the chicken progesterone receptor.6538613Dicker PD, Tsai SY, Weigel NL, Tsai MJ, Schrader WT, O'Malley BWJournal of steroid biochemistryMonoclonal antibody to the hen oviduct progesterone receptor produced following in vitro immunization. J Steroid Biochem. 1984 Jan; 20(1):43-50.J Steroid Biochem1984-01-01T00:00:001984Monoclonal antibody to the hen oviduct progesterone receptor produced following in vitro immunization.6754732Weigel N, Powers DA, Roseman SThe Journal of biological chemistrySugar transport by the bacterial phosphotransferase system. Primary structure and active site of a general phosphocarrier protein (HPr) from Salmonella typhimurium. J Biol Chem. 1982 Dec 10; 257(23):14499-509.J Biol Chem1982-12-10T00:00:001982Sugar transport by the bacterial phosphotransferase system. Primary structure and active site of a general phosphocarrier protein (HPr) from Salmonella typhimurium.7476977Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NLMolecular endocrinology (Baltimore, Md.)Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol. 1995 Aug; 9(8):1029-40.Mol Endocrinol1995-08-01T00:00:001995Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor.7740165O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JHRecent progress in hormone researchAn alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res. 1995; 50:333-47.Recent Prog Horm Res1995-01-01T00:00:001995An alternative ligand-independent pathway for activation of steroid receptors.7877616Bai W, Tullos S, Weigel NLMolecular endocrinology (Baltimore, Md.)Phosphorylation of Ser530 facilitates hormone-dependent transcriptional activation of the chicken progesterone receptor. Mol Endocrinol. 1994 Nov; 8(11):1465-73.Mol Endocrinol1994-11-01T00:00:001994Phosphorylation of Ser530 facilitates hormone-dependent transcriptional activation of the chicken progesterone receptor.8373763Poletti A, Conneely OM, McDonnell DP, Schrader WT, O'Malley BW, Weigel NLBiochemistryChicken progesterone receptor expressed in Saccharomyces cerevisiae is correctly phosphorylated at all four Ser-Pro phosphorylation sites. Biochemistry. 1993 Sep 21; 32(37):9563-9.Biochemistry1993-09-21T00:00:001993Chicken progesterone receptor expressed in Saccharomyces cerevisiae is correctly phosphorylated at all four Ser-Pro phosphorylation sites.8662804Bai W, Weigel NLThe Journal of biological chemistryPhosphorylation of Ser211 in the chicken progesterone receptor modulates its transcriptional activity. J Biol Chem. 1996 May 31; 271(22):12801-6.J Biol Chem1996-05-31T00:00:001996Phosphorylation of Ser211 in the chicken progesterone receptor modulates its transcriptional activity.8993337Allgood VE, Zhang Y, O'Malley BW, Weigel NLBiochemistryAnalysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer. Biochemistry. 1997 Jan 07; 36(1):224-32.Biochemistry1997-01-07T00:00:001997Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer.9099688Bai W, Rowan BG, Allgood VE, O'Malley BW, Weigel NLThe Journal of biological chemistryDifferential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation. J Biol Chem. 1997 Apr 18; 272(16):10457-63.J Biol Chem1997-04-18T00:00:001997Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation.1316867Poletti A, Weigel NL, McDonnell DP, Schrader WT, O'Malley BW, Conneely OMGeneA novel, highly regulated, rapidly inducible system for the expression of chicken progesterone receptor, cPRA, in Saccharomyces cerevisiae. Gene. 1992 May 01; 114(1):51-8.Gene1992-05-01T00:00:001992A novel, highly regulated, rapidly inducible system for the expression of chicken progesterone receptor, cPRA, in Saccharomyces cerevisiae.9660165Weigel NL, Zhang YJournal of molecular medicine (Berlin, Germany)Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl). 1998 Jun; 76(7):469-79.J Mol Med (Berl)1998-06-01T00:00:001998Ligand-independent activation of steroid hormone receptors.Authorship 8725091028591703Roberts JM, Martin RS, Piyarathna DB, MacKrell JG, Rocha GV, Dodge JA, Coarfa C, Krishnan V, Rowley DR, Weigel NLOncotargetVitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG. Oncotarget. 2017 Jul 04; 8(27):44447-44464.Oncotarget2017-07-04T00:00:002017Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.10354410Labaree DC, Hoyte RM, Nazareth LV, Weigel NL, Hochberg RBJournal of medicinal chemistry7alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents. J Med Chem. 1999 Jun 03; 42(11):2021-34.J Med Chem1999-06-03T00:00:0019997alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents.10587588Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti AHuman molecular geneticsMotoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet. 2000 Jan 01; 9(1):133-44.Hum Mol Genet2000-01-01T00:00:002000Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract.10598582Nazareth LV, Stenoien DL, Bingman WE, James AJ, Wu C, Zhang Y, Edwards DP, Mancini M, Marcelli M, Lamb DJ, Weigel NLMolecular endocrinology (Baltimore, Md.)A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1) Mol Endocrinol. 1999 Dec; 13(12):2065-75.Mol Endocrinol1999-12-01T00:00:001999A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)10628747Clemm DL, Sherman L, Boonyaratanakornkit V, Schrader WT, Weigel NL, Edwards DPMolecular endocrinology (Baltimore, Md.)Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol. 2000 Jan; 14(1):52-65.Mol Endocrinol2000-01-01T00:00:002000Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody.11073973Rowan BG, Garrison N, Weigel NL, O'Malley BWMolecular and cellular biology8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol. 2000 Dec; 20(23):8720-30.Mol Cell Biol2000-12-01T00:00:0020008-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein.11345899Lamb DJ, Weigel NL, Marcelli MVitamins and hormonesAndrogen receptors and their biology. Vitam Horm. 2001; 62:199-230.Vitam Horm2001-01-01T00:00:002001Androgen receptors and their biology.11746268Polek TC, Murthy S, Blutt SE, Boehm MF, Zou A, Weigel NL, Allegretto EAThe ProstateNovel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium. Prostate. 2001 Nov 01; 49(3):224-33.Prostate2001-11-01T00:00:002001Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.15044710Stewart LV, Weigel NLExperimental biology and medicine (Maywood, N.J.)Vitamin D and prostate cancer. Exp Biol Med (Maywood). 2004 Apr; 229(4):277-84.Exp Biol Med (Maywood)2004-04-01T00:00:002004Vitamin D and prostate cancer.15585637Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray RClinical cancer research : an official journal of the American Association for Cancer ResearchInhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res. 2004 Dec 01; 10(23):8018-27.Clin Cancer Res2004-12-01T00:00:002004Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.16076555Stewart LV, Lyles B, Lin MF, Weigel NLThe Journal of steroid biochemistry and molecular biologyVitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. J Steroid Biochem Mol Biol. 2005 Oct; 97(1-2):37-46.J Steroid Biochem Mol Biol2005-08-01T00:00:002005Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.16619264Agoulnik IU, Weigel NLJournal of cellular biochemistryAndrogen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem. 2006 Oct 01; 99(2):362-72.J Cell Biochem2006-10-01T00:00:002006Androgen receptor action in hormone-dependent and recurrent prostate cancer.17079484Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NLCancer researchAndrogens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res. 2006 Nov 01; 66(21):10594-602.Cancer Res2006-11-01T00:00:002006Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.Authorship 105334417536004Weigel NL, Moore NLMolecular endocrinology (Baltimore, Md.)Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol. 2007 Oct; 21(10):2311-9.Mol Endocrinol2007-05-29T00:00:002007Steroid receptor phosphorylation: a key modulator of multiple receptor functions.Authorship 104347219584267Bhatia V, Mula RV, Weigel NL, Falzon MMolecular cancer research : MCRParathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res. 2009 Jul; 7(7):1119-31.Mol Cancer Res2009-07-07T00:00:002009Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.2318886Bagchi MK, Tsai SY, Weigel NL, Tsai MJ, O'Malley BWThe Journal of biological chemistryRegulation of in vitro transcription by progesterone receptor. Characterization and kinetic studies. J Biol Chem. 1990 Mar 25; 265(9):5129-34.J Biol Chem1990-03-25T00:00:001990Regulation of in vitro transcription by progesterone receptor. Characterization and kinetic studies.20632309Washington MN, Kim JS, Weigel NLThe Prostate1a,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest. Prostate. 2011 Jan 01; 71(1):98-110.Prostate2011-01-01T00:00:0020111a,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.22622222Searle NS, Teal CR, Richards BF, Friedland JA, Weigel NL, Hernandez RA, Lomax JW, Coburn M, Nelson EAAcademic medicine : journal of the Association of American Medical CollegesA standards-based, peer-reviewed teaching award to enhance a medical school's teaching environment and inform the promotions process. Acad Med. 2012 Jul; 87(7):870-6.Acad Med2012-07-01T00:00:002012A standards-based, peer-reviewed teaching award to enhance a medical school's teaching environment and inform the promotions process.Authorship 8817872429258679Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj GVEuropean urologyRole of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. Eur Urol. 2018 05; 73(5):715-723.Eur Urol2017-12-16T00:00:002017Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.Authorship 1051512true1Associate ProfessorAssociate Professortrue1ProfessorProfessorD011944Chemicals & Drugs2908750.646186Receptors, AndrogenD011980Chemicals & Drugs31813910.64583Receptors, ProgesteroneD011471Disorders75157520.293197Prostatic NeoplasmsAuthorship 1078973Authorship 1032848D018167Chemicals & Drugs811340.918751Receptors, CalcitriolD002117Chemicals & Drugs661270.934687CalcitriolAuthorship 92459214Authorship 934501829764864Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, Wells C, Lee S, Zuehlke AD, Shao H, Bingman WE, Kumar V, Malhotra SV, Weigel NL, Gestwicki JE, Trepel JB, Neckers LMCancer researchTargeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer. Cancer Res. 2018 07 15; 78(14):4022-4035.Cancer Res2018-05-15T00:00:002018Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.30228349Zhang M, Suarez E, Vasquez JL, Nathanson L, Peterson LE, Rajapakshe K, Basil P, Weigel NL, Coarfa C, Agoulnik IUOncogeneInositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity. Oncogene. 2019 02; 38(7):1121-1135.Oncogene2018-09-18T00:00:002018Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.2010-04-30NIHWEIGEL, NANCY LYNN2004-06-02Targets of Vitamin D Receptor Action in ProstateR01CA1076911995-06-30NIHWEIGEL, NANCY LYNN1986-07-01REGULATION OF PROGESTERONE RECEPTORS BY PHOSPHORYLATIONR01HD0220611993-03-31NIHWEIGEL, NANCY LYNN1992-09-30REGULATION OF HUMAN STEROID RECEPTORS BY PHOSPHORYLATIONR55CA0575392012-07-31NIHWEIGEL, NANCY LYNN1993-04-15Regulation of Human Steroid Receptors by PhosphorylationR01CA0575392004-11-30NIHWEIGEL, NANCY LYNN1998-12-24INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN DR01CA0753372006-01-31NIHWEIGEL, NANCY LYNN2005-02-18Conference on Hormonal Regulation of TumorigenesisR13CA1129242008-05-31NIHWEIGEL, NANCY LYNN2003-08-01Coactivators and Androgen Receptors in Prostate CancerR01DK065252Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorDepartment of Molecular & Cellular BiologyDepartment of Molecular Virology & MicrobiologyDepartment of Pathology & ImmunologyMolecular & Cellular BiologyMolecular Virology & MicrobiologyPathologyBaylor College of MedicineCRISTIANCOARFACRISTIAN COARFA0.000000000000000.000000000000001149COARFA, CRISTIANAssociate ProfessorSARAHBLUTTSARAH BLUTT0.000000000000000.000000000000002152BLUTT, SARAHAssociate ProfessorSOPHIATSAISOPHIA TSAI0.000000000000000.000000000000002539TSAI, SOPHIADistinguished Emeritus Professor5.95270.00127199578research areas2.806990.013111952coauthor of84.76919.021160similar to11151selected publicationsARUNSREEKUMARARUN SREEKUMAR39.09225730000000-77.209617300000001838SREEKUMAR, ARUNProfessorMICHAELLEWISMICHAEL LEWIS0.000000000000000.00000000000000353LEWIS, MICHAELProfessorMING-JERTSAIMING-JER TSAI0.000000000000000.000000000000002538TSAI, MING-JERDistinguished Service Professor EmeritusFRANCESCODEMAYOFRANCESCO DEMAYO0.000000000000000.000000000000003030DEMAYO, FRANCESCOAdjunct ProfessorBERTO'MALLEYBERT O'MALLEY0.000000000000000.000000000000002464O'MALLEY, BERTDistinguished Service ProfessorMICHAELITTMANNMICHAEL ITTMANN0.000000000000000.000000000000002694ITTMANN, MICHAELProfessorIRINAAGOULNIKIRINA AGOULNIK0.000000000000000.000000000000003486AGOULNIK, IRINAAdjunct Associate ProfessorAuthorship 1268433Authorship 128871123838532Trevi?o LS, Weigel NLTrends in endocrinology and metabolism: TEMPhosphorylation: a fundamental regulator of steroid receptor action. Trends Endocrinol Metab. 2013 Oct; 24(10):515-24.Trends Endocrinol Metab2013-07-06T00:00:002013Phosphorylation: a fundamental regulator of steroid receptor action.23859952Shafi AA, Yen AE, Weigel NLPharmacology & therapeuticsAndrogen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther. 2013 Dec; 140(3):223-38.Pharmacol Ther2013-07-13T00:00:002013Androgen receptors in hormone-dependent and castration-resistant prostate cancer.true1ProfessorProfessortrue1Distinguished Service ProfessorDistinguished Service ProfessorAuthorship 1119133true1Adjunct Associate ProfessorAdjunct Associate Professortrue1Distinguished Emeritus ProfessorDistinguished Emeritus ProfessorAuthorship 1110367Authorship 1134575Authorship 116332true1Adjunct ProfessorAdjunct ProfessorAuthorship 1147304Authorship 1006685633300995Nagandla H, Robertson MJ, Putluri V, Putluri N, Coarfa C, Weigel NLEndocrinologyIsoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells. Endocrinology. 2021 03 01; 162(3).Endocrinology2021-03-01T00:00:002021Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells.Authorship 1008851633446905Rana M, Dong J, Robertson MJ, Basil P, Coarfa C, Weigel NLScientific reportsAndrogen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells. Sci Rep. 2021 01 14; 11(1):1393.Sci Rep2021-01-14T00:00:002021Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells.Authorship 1018300633976356Rana M, Dong J, Robertson MJ, Basil P, Coarfa C, Weigel NLScientific reportsAuthor Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells. Sci Rep. 2021 May 11; 11(1):10437.Sci Rep2021-05-11T00:00:002021Author Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells.Authorship 1219263Authorship 122665true1Associate ProfessorAssociate ProfessorAuthorship 1175345SANDRAGRIMMSANDRA GRIMM17188GRIMM, SANDRAAssistant ProfessorAuthorship 1183903Authorship 1041717935354884Basil P, Robertson MJ, Bingman WE, Dash AK, Krause WC, Shafi AA, Piyarathna B, Coarfa C, Weigel NLScientific reportsCistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities. Sci Rep. 2022 03 30; 12(1):5351.Sci Rep2022-03-30T00:00:002022Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities.Authorship 1206444Authorship 1207261Authorship 1198059true1Assistant ProfessorAssistant ProfessorAuthorship 10546861735954173Ravindran A, Krieger KL, Kaushik AK, Hovington H, Mehdi S, Piyarathna DWB, Putluri V, Basil P, Rasaily U, Gu F, Dang T, Choi JM, Sonavane R, Jung SY, Wang L, Mehra R, Weigel NL, Putluri N, Rowley DR, Palapattu GS, Guillemette C, Lacombe L, L?vesque ?, Sreekumar ACellsUridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients. Cells. 2022 07 29; 11(15).Cells2022-07-29T00:00:002022Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients.Authorship 1223252Authorship 176035Authorship 181543Authorship 13134true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Professor EmeritusProfessor EmeritusAuthorship 138522Authorship 153147true1Distinguished Service Professor EmeritusDistinguished Service Professor Emeritustrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 248074Authorship 194984Authorship 284275Authorship 301093Authorship 21854824359151Kaushik AK, Vareed SK, Basu S, Putluri V, Putluri N, Panzitt K, Brennan CA, Chinnaiyan AM, Vergara IA, Erho N, Weigel NL, Mitsiades N, Shojaie A, Palapattu G, Michailidis G, Sreekumar AJournal of proteome researchMetabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer. J Proteome Res. 2014 Feb 07; 13(2):1088-100.J Proteome Res2013-12-31T00:00:002013Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.Authorship 252871Authorship 254534Authorship 373946Authorship 264603Authorship 275991Authorship 292682Authorship 13958310Authorship 451613Authorship 463172Authorship 326246Authorship 345444Authorship 474082Authorship 143415Authorship 356462Authorship 530567Authorship 360962Authorship 538734Authorship 363173Authorship 3641Authorship 403011Authorship 596415Authorship 60954Authorship 619632Authorship 627718Authorship 451833Authorship 63036Authorship 649021Authorship 485022Authorship 487844Authorship 498932Authorship 6993Authorship 707822Authorship 534048Authorship 758876Authorship 560003Authorship 555972Authorship 811018Authorship 817165Authorship 568462Authorship 571602Authorship 829795Authorship 591036Authorship 592224Authorship 604731Authorship 850626Authorship 1506974Authorship 1512777Authorship 151603524926821Kim JS, Roberts JM, Bingman WE, Shao L, Wang J, Ittmann MM, Weigel NLEndocrinologyThe prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling. Endocrinology. 2014 Sep; 155(9):3262-73.Endocrinology2014-06-13T00:00:002014The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.25008967Krause WC, Shafi AA, Nakka M, Weigel NLThe international journal of biochemistry & cell biologyAndrogen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells. Int J Biochem Cell Biol. 2014 Sep; 54:49-59.Int J Biochem Cell Biol2014-07-04T00:00:002014Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.25178514Rechoum Y, Rovito D, Iacopetta D, Barone I, And? S, Weigel NL, O'Malley BW, Brown PH, Fuqua SABreast cancer research and treatmentAR collaborates with ERa in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat. 2014 Oct; 147(3):473-85.Breast Cancer Res Treat2014-09-02T00:00:002014AR collaborates with ERa in aromatase inhibitor-resistant breast cancer.Authorship 872841Authorship 62614Authorship 152906325220500Moore NL, Edwards DP, Weigel NLThe Journal of steroid biochemistry and molecular biologyCyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. J Steroid Biochem Mol Biol. 2014 Oct; 144 Pt B:471-82.J Steroid Biochem Mol Biol2014-09-16T00:00:002014Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.Authorship 95853Authorship 676924Authorship 714592Authorship 70082Authorship 739154Authorship 728907Authorship 73933Authorship 7841810Authorship 15542619Authorship 15548712